Found: 25
Select item for more details and to access through your institution.
Caveolin-1 deficiency induces a MEK- ERK1/2-Snail-1-dependent epithelial-mesenchymal transition and fibrosis during peritoneal dialysis.
- Published in:
- EMBO Molecular Medicine, 2015, v. 7, n. 3, p. 357, doi. 10.15252/emmm.201570010
- By:
- Publication type:
- Article
Caveolin-1 deficiency induces a MEK- ERK1/2-Snail-1-dependent epithelial-mesenchymal transition and fibrosis during peritoneal dialysis.
- Published in:
- EMBO Molecular Medicine, 2015, v. 7, n. 1, p. 102, doi. 10.15252/emmm.201404127
- By:
- Publication type:
- Article
ROR1-STAT3 signaling contributes to ovarian cancer intra-tumor heterogeneity.
- Published in:
- Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01527-6
- By:
- Publication type:
- Article
Inhibition of Transforming Growth Factor-Activated Kinase 1 (TAK1) Blocks and Reverses Epithelial to Mesenchymal Transition of Mesothelial Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031492
- By:
- Publication type:
- Article
Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 877, doi. 10.3390/cancers12040877
- By:
- Publication type:
- Article
Adverse prognostic impact of regulatory T‐cells in testicular diffuse large B‐cell lymphoma.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 6, p. 712, doi. 10.1111/ejh.13484
- By:
- Publication type:
- Article
E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 12, p. 2312, doi. 10.1002/1878-0261.13159
- By:
- Publication type:
- Article
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 9, p. 1639, doi. 10.1002/1878-0261.12347
- By:
- Publication type:
- Article
Low nuclear expression of HIF‐hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence‐free survival in clear cell renal cell carcinoma.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.6998
- By:
- Publication type:
- Article
SHARPIN is an endogenous inhibitor of ?1-integrin activation.
- Published in:
- Nature Cell Biology, 2011, v. 13, n. 11, p. 1315, doi. 10.1038/ncb2340
- By:
- Publication type:
- Article
Negative regulation of EGFR signalling through integrin-a<sub>1</sub>ß<sub>1</sub>-mediated activation of protein tyrosine phosphatase TCPTP.
- Published in:
- Nature Cell Biology, 2005, v. 7, n. 1, p. 78, doi. 10.1038/ncb1209
- By:
- Publication type:
- Article
Cancer‐associated fibroblast activation predicts progression, metastasis, and prognosis of cutaneous squamous cell carcinoma.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 6, p. 1112, doi. 10.1002/ijc.34957
- By:
- Publication type:
- Article
Distinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinoma.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-07004-9
- By:
- Publication type:
- Article
Distinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinoma.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-07004-9
- By:
- Publication type:
- Article
Fibroblast as a critical stromal cell type determining prognosis in prostate cancer.
- Published in:
- Prostate, 2019, v. 79, n. 13, p. 1505, doi. 10.1002/pros.23867
- By:
- Publication type:
- Article
Competitive binding of Rab21 and p120RasGAP to integrins regulates receptor traffic and migration.
- Published in:
- Journal of Cell Biology, 2011, v. 194, n. 2, p. 291, doi. 10.1083/jcb.201012126
- By:
- Publication type:
- Article
Small GTPase Rab21 regulates cell adhesion and controls endosomal traffic of 131-integrins.
- Published in:
- Journal of Cell Biology, 2006, v. 173, n. 5, p. 767, doi. 10.1083/jcb.200509019
- By:
- Publication type:
- Article
Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient‐derived cancer cells.
- Published in:
- International Journal of Cancer, 2019, v. 144, n. 6, p. 1356, doi. 10.1002/ijc.31815
- By:
- Publication type:
- Article
Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 4, p. 678, doi. 10.1038/s41416-022-02067-z
- By:
- Publication type:
- Article
High tumor cell platelet‐derived growth factor receptor beta expression is associated with shorter survival in malignant pleural epithelioid mesothelioma.
- Published in:
- Journal of Pathology: Clinical Research, 2021, v. 7, n. 5, p. 482, doi. 10.1002/cjp2.218
- By:
- Publication type:
- Article
Combined epithelial marker analysis of tumour budding in stage II colorectal cancer.
- Published in:
- Journal of Pathology: Clinical Research, 2019, v. 5, n. 1, p. 63, doi. 10.1002/cjp2.119
- By:
- Publication type:
- Article
SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer.
- Published in:
- Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2017.00956
- By:
- Publication type:
- Article
A simple heterogeneous one-step assay for screening estrogenic compounds.
- Published in:
- Biotechnology Letters, 2013, v. 35, n. 1, p. 47, doi. 10.1007/s10529-012-1050-0
- By:
- Publication type:
- Article
Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid Mesothelioma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.870352
- By:
- Publication type:
- Article
Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 1, p. 71, doi. 10.1093/jnci/djac178
- By:
- Publication type:
- Article